However, in various biochemical and cellular assays we found that the interaction of CA-125 with mesothelin was not strong enough to block binding of the Fab moiety that targets RG7787 to tumor cells indicating that soluble CA-125 levels in patients cannot antagonize RG7787 treatment. The gene discussed is MUC16; the disease is neoplasm.